Millrace Asset Group, Inc. Chembio Diagnostics, Inc. Transaction History

Millrace Asset Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$3.18 - $15.54 $521,062 - $2.55 Million	-163,856 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$2.36 - $5.6 $386,700 - $917,593	163,856 New	163,856 $839,000
Q4 2019 Feb 13, 2020	SELL	$3.94 - $5.76 $584,101 - $853,914	-148,249 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$4.84 - $7.25 $263,044 - $394,023	-54,348 Reduced 26.83%	148,249 $907,000
Q2 2019 Aug 13, 2019	SELL	$5.56 - $7.85 $434,391 - $613,304	-78,128 Reduced 27.83%	202,597 $1.23 Million
Q1 2019 May 14, 2019	BUY	$5.32 - $7.18 $215,454 - $290,782	40,499 Added 16.86%	280,725 $1.56 Million
Q4 2018 Feb 13, 2019	BUY	$4.95 - $10.5 $1.19 Million - $2.52 Million	240,226 New	240,226 $1.36 Million

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Millrace Asset Group, Inc. with notifications on news.